# Glioma Disease Research Run

Run timestamp: 2026-05-08T11:11:27Z

## Selected Focus

Glioma.

## Why This Was Selected

The MR-RATE disease research manifest showed `glioma` as the first disease
category that had not reached the final thorough-research target after
intracranial meningioma.

## Work Performed

- Expanded the disease evidence pack to the thorough-research target:
  - 50 source records.
  - 25 figure or image evidence records.
  - 15 video or teaching evidence records.
- Created the disease chapter:
  - `glioma.md`
- Updated supporting research artifacts:
  - `research-plan.md`
  - `source-review.md`
  - `differential-matrix.md`
  - `sources.json`
  - `figures.json`
  - `videos.json`
- Created disease-specific alias artifacts:
  - `glioma.research-plan.md`
  - `glioma.source-review.md`
  - `glioma.sources.json`
  - `glioma.figures.json`
  - `glioma.videos.json`
- Updated restart and review surfaces:
  - `manifest.json`
  - `TODO.md`
  - `reports/index.html`
- Rendered the disease HTML preview:
  - `reports/diseases/glioma.html`

## Source Areas Reviewed

- EANO adult diffuse glioma guideline.
- NICE adult brain tumor guidance.
- WHO 2021 CNS tumor and adult-type diffuse glioma classification reviews.
- ACR brain tumor imaging appropriateness context.
- BTIP MRI acquisition protocol sources.
- RANO 2.0, RANO operationalization, and iRANO response-assessment sources.
- NCI / NCBI / StatPearls clinical and treatment references.
- Broad and advanced MRI reviews for perfusion, diffusion, spectroscopy,
  amino-acid PET, radiogenomics, and treatment effect.
- Differential sources for brain metastasis, abscess, lymphoma, tumefactive
  demyelination, infarct, radiation necrosis, pseudoprogression, and cavernous
  malformation.

## Commands And Checks

Generated artifacts:

```powershell
python docs/clinical-statistical-expert/mr-rate-disease-research/runs/_tmp_build_glioma.py
```

Result:

```json
{
  "ok": true,
  "disease": "glioma",
  "counts": {
    "sources": 50,
    "figures": 25,
    "videos": 15
  },
  "status": "final_thorough_research_target_met_needs_human_review"
}
```

Validated disease JSON artifacts:

```powershell
python -c "load sources.json, figures.json, videos.json, and disease-specific aliases"
```

Result:

```text
json ok: sources.json, figures.json, videos.json, glioma.sources.json, glioma.figures.json, glioma.videos.json
```

Validated manifest JSON:

```powershell
python -c "load manifest.json"
```

Result:

```text
json ok: manifest.json
```

Checked disease chapter against the clinical-statistical-expert disease
template:

```powershell
python -m skillforge disease-template-check glioma --disease-dir docs/clinical-statistical-expert/mr-rate-disease-research/diseases/glioma --json
```

Result:

```text
ok: true
required conceptual headings present
all template headings match exactly
50 sources recorded
25 figures recorded
```

Rendered HTML preview:

```powershell
python -m skillforge disease-preview glioma --disease-dir docs/clinical-statistical-expert/mr-rate-disease-research/diseases/glioma --output docs/clinical-statistical-expert/mr-rate-disease-research/reports/diseases/glioma.html --json
```

Result:

```text
ok: true
sources_total: 50
figures_total: 25
local_figures: 0
```

## What Worked

- The manifest-driven queue correctly selected the next below-target disease.
- The disease chapter passed the template conformance check, including strict
  heading matching.
- The source set covers clinical guidelines, WHO 2021 classification, imaging
  protocols, response criteria, molecular context, advanced imaging, treatment
  effect, and major mimics.
- The chapter explicitly separates suspected glioma, pathology-confirmed
  glioma, treated glioma, progression, pseudoprogression, radiation necrosis,
  and nonspecific mass language.

## What Could Be Improved

- Figure evidence remains link-only until reuse rights are reviewed.
- Video and teaching evidence records were curated, but transcripts were not
  reviewed in this cycle.
- The chapter would benefit from compact tables for WHO 2021 subtype logic,
  RANO 2.0 response categories, report-language adjudication, and
  treatment-effect mimics.
- Subtype-specific management and molecular claims need expert review before
  publication-grade use.

## Blockers Or Gaps

- No private clinical data was processed.
- No large dependencies, models, GPU jobs, credentials, merge, or push were
  used.
- Human expert review is still needed before treating this as final
  clinical-statistical content.

## Next Action

Continue the MR-RATE queue with `schwannoma`, unless the user wants a human
review pass on glioma first.
